Antiphospholipid antibody syndrome (APLA) is a non-inflammatory autoimmune disease characterised by spontaneous abortion, thrombocytopenia and thrombosis (arterial and venous). Intracardiac thrombosis is a rare complication of APLA, but coronary sinus thrombosis in APLA has hitherto not been reported. We recently treated a young woman with secondary APLA and systemic lupus erythematosus in whom coronary sinus thrombosis was detected in association with recurrent pulmonary embolism.
Introduction
The frequency of thrombosis is reported to be greater in APLA associated with systemic lupus erythematosus (SLE) than in primary APLA; risk factors have also been found to differ for venous and arterial thrombosis in APLA. 2 Coronary sinus thrombosis usually occurs as a complication of cardiac transplantation and right heart catheterization in non-infected patients, and rarely in the absence of such procedures. 3 Coronary sinus thrombosis in APLA has hitherto not been reported. We recently treated a young woman with secondary APLA and SLE in whom coronary sinus thrombosis was detected in association with recurrent pulmonary embolism. Two-dimensional transthoracic echocardiography revealed normal dimensions of the left ventricle and left atrium. Doppler echocardiography of the heart revealed moderate pulmonary hypertension, with the pulmonary arterial systolic pressure exceeding 50 mmHg. A hyperechoic signal was obtained at the site of entry of the coronary sinus into the right atrium (Fig. 1A) . In view of these findings, transesophageal echocardiography was performed and this confirmed the presence of a mobile, friable mass in the coronary sinus (Fig. 1B) . A spiral computerized tomograph of the chest showed occlusion of multiple right lower lobe segmental arteries with a calcified thrombus in the coronary sinus at the site of entry into the right atrium (Fig. 2) . Further investigations revealed that the patient was suffering from systemic lupus erythematosus with secondary antiphospholipid antibody syndrome (APLA), which was the possible cause of the thrombosis. Oral anticoagulant therapy was commenced (warfarin sodium, 3 mg once daily), and the prothrombin time (INR) was maintained at 2.5. The patient underwent surgery. During cardiopulmonary bypass, the coronary sinus was opened and the mass was removed. Histological examination of the mass revealed an organized thrombus with a fibrinous network and calcification. The patient experienced no postoperative complications. Echocardiogram was repeated after two weeks; this showed a considerable decrease in pulmonary systolic pressure and a patent coronary sinus. The patient is currently being reviewed on a regular basis, and continues to receive warfarin, steroids, amlodipine and thyroxine
Case Report

Discussion
The coronary sinus is the conduit at the posterior atrioventricular groove which drains into the right atrium. Coronary sinus thrombosis is a rare acquired anomaly. Although cases of primary coronary sinus thrombosis have been reported, most cases occur due to endothelial damage following invasive cardiac procedures involving the right atrium, such as central venous line placement, right ventricle pacing, cardiac resynchornising therapy and cardiac transplant. [4] [5] [6] Aspergillus fumigatus thrombi causing total occlusion of both coronary arterial ostia, all four major epicardial coronary arteries and coronary sinus and associated with purulent pericarditis has also been reported. 7 APLA is characterized by arterial and venous thrombosis. [8] [9] [10] The frequency of thrombosis and pregnancy loss (another feature of APLA) is greater in APLA associated with SLE than in primary APLA. 2, 10 Intracardiac thrombus has rarely been reported as a complication of APLA. 10 To our knowledge, primary coronary sinus thrombosis due to SLE with secondary APLA has hitherto not been reported. A search of the Pub Med database using the keywords `coronary sinus thrombosis' and antiphospholipid antibody syndrome' only generated two results (neither were relevant in the context of the present case) ; the use of the keywords `coronary sinus thrombosis' and `systemic lupus erythematosus' also generated two references that were not relevant to the present context.
The clinical course of coronary sinus thrombosis is unpredictable. Most cases remain asymptomatic and are detected only incidentally at angiography done for other purposes or at autopsy. Fatal complications, such as sudden cardiac death, venous haemorrhagic myocardial infarction and pericardial tamponade have been reported. [3] [4] [5] [6] It can also serve as a nidus for recurrent pulmonary embolism and lead to pulmonary hypertension, as in our patient. In symptomatic patients, heparin therapy followed by oral anticoagulants and open heart thrombectomy may be rewarding.
Conclusion
APLA is a non-inflammatory autoimmune disease c h a r a c t e r i s e d b y s p o n t a n e o u s a b o r t i o n , thrombocytopenia and thrombosis (arterial and venous). Intracardiac thrombosis is a rare complication of APLA, To our knowledge, primary coronary sinus thrombosis due to systemic lupus erythematosus with secondary APLA has hitherto not been reported. Coronary sinus thrombosis can be a source of recurrent pulmonary embolism as in our patient. Additional cases and reports are needed to confirm that the coronary sinus may serve as another site of thrombosis, which can lead to pulmonary embolism Oral anticoagulants and resection of the thrombus enabled our patient to recover without major complications.
